Highline Wealth Partners’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
Other funds holding LH
RRAM
JIC
BCWM
AAM
DIA
SFA
WCM
HPCM
MCM
ET
Highline Wealth Partners's LH Position: Q2 2026 in Review
Highline Wealth Partners increased its Labcorp (LH) stake by 100% in Q2 2026, buying an estimated $1.84K and bringing the position to 14 shares worth $3.92K. The position accounts for ﹤0.01% of the portfolio, ranked #920.
Highline Wealth Partners first reported a position in LH in Q1 2025 and has held it in 6 quarters since. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Highline Wealth Partners held 14 shares of Labcorp worth $3.92K as of Q2 2026.
- Highline Wealth Partners bought 7 Labcorp shares in Q2 2026, an estimated $1.84K.
- Labcorp made up ﹤0.01% of Highline Wealth Partners's portfolio in Q2 2026, its #920 holding.
- Highline Wealth Partners first reported a position in Labcorp in Q1 2025 and has held it in 6 quarters since.
- 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Highline Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.